Antidiabetic effect through islet cell protection in streptozotocin diabetes: A preliminary assessment of two thiazolidin-4-ones in Swiss albino mice

Chemico-Biological Interactions

Volumn 177, Issue 3, 2009, Pages 242-246

  Kishore, Anoop ^a   Nampurath, Gopalan Kutty ^a   Mathew, Suma P ^a   Zachariah, Robby T ^a   Potu, Bhagath Kumar ^b   Rao, Muddanna S ^b   Valiathan, Manna ^b   Chamallamudi, Mallikarjuna Rao ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Hypoglycaemic; Hypolipidaemic; Nicotinic acid; Thiazolidin 4 ones

Indexed keywords

GLUCOSE; N [2 (4 METHOXYPHENYL) 4 OXOTHIAZOLIDIN 3 YL] NICOTINAMIDE; N [2 [3,5 BIS(TERT BUTYL 4 HYDROXYPHENYL)] 4 OXOTHIAZOLIDIN 3 YL]NICOTINAMIDE; NICOTINIC ACID; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIABETES CONTROL; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; STREPTOZOCIN DIABETES; SWISS WEBSTER MOUSE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; MALE; MICE; NIACINAMIDE; STREPTOZOCIN;

MUS; RATTUS;

EID: 58349108316     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.10.032     Document Type: Article

References (12)

1. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
2. Yoon K.H., Ko S.H., Cho J.H., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea. J. Clin. Endocrinol. Metabol. 88 (2003) 2300-2308
3. Bonner-Weir S., Deery D., Leahy J.L., and Weir G.C. Compensatory growth of pancreatic beta cells in adult rats after short-term glucose infusion. Diabetes 38 (1989) 49-53
4. Bouwens L., and Rooman I. Regulation of pancreatic beta-cell mass. Physiol. Rev. 85 (2005) 1255-1270
5. Alonso L.C., Yokoe T., Zhang P., Scott D.K., Kim S.K., O'Donnell C.P., and Garcia-Ocaria A. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 56 (2007) 1792-1801
6. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaaire-Buys D., Novelli M., and Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47 (1998) 224-229
7. Jacob N., and Kutty N.G. Synthesis and hypolipidaemic activity of a thiazolidinone derivative. Ind. Drugs 41 (2004) 76-79
8. Joy J.M., Jacob N., and Kutty G.N. Evaluation of hypoglycemic effects of 4-thiazolidinones. Ind. Drugs 42 (2005) 47
9. Nampurath G.K., Mathew S.P., Khanna V., Zachariah R.T., Kanji S., and Rao C.M. Assessment of hypolipidaemic activity of three thiazolidine-4-ones in mice given high-fat diet and fructose. Chem.-Biol. Interact. 171 (2008) 363-368
10. Kalia R., Rao C.M., and Kutty N.G. Synthesis and evaluation of the anti-inflammatory activity of N-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxothiazolidin-3-yl]-nicotinamide. Arzneimittel-Forschung. 57 (2007) 616-622
11. Mahley R.W., and Bersot T.P. Drug therapy for hypercholesterolemia and dyslipidemia. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics (2001), McGraw-Hill, New York 971-1002
12. Root M.A., and Ashmore J. The hypoglycemic activity of nicotinic acid in rats. Naunyn-Schmiedebergs Arch. u. Path. u. Pharmak. 248 (1964) 117-123